Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoyuki Horie

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer Letters|August 23, 2005
The third-generation bisphosphonates inhibit proliferation of murine osteosarcoma cells with induction of apoptosisNaoyuki Horie, Hiroaki Murata, Yasunori Nishigaki, et al.
International Journal of Oncology|December 18, 2012
Zoledronic acid significantly enhances radiation‑induced apoptosis against human fibrosarcoma cells by inhibiting radioadaptive signalingKazutaka Koto, Hiroaki Murata, Shinya Kimura, et al.
Cancer Letters|November 7, 2008
Clinically relevant dose of zoledronic acid inhibits spontaneous lung metastasis in a murine osteosarcoma modelKazutaka Koto, Naoyuki Horie, Shinya Kimura, et al.
Oncology Reports|December 21, 2012
Effectiveness of sulforaphane as a radiosensitizer for murine osteosarcoma cellsYasushi Sawai, Hiroaki Murata, Motoyuki Horii, et al.
Oncology Reports|June 2, 2010
Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agentsKazutaka Koto, Hiroaki Murata, Shinya Kimura, et al.
Anticancer Research|August 5, 2010
Combined effects of bisphosphonate and radiation on osteosarcoma cellsKazuteru Ryu, Hiroaki Murata, Kazutaka Koto, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Letters|August 23, 2005
The third-generation bisphosphonates inhibit proliferation of murine osteosarcoma cells with induction of apoptosisNaoyuki Horie, Hiroaki Murata, Yasunori Nishigaki, et al.
International Journal of Oncology|December 18, 2012
Zoledronic acid significantly enhances radiation‑induced apoptosis against human fibrosarcoma cells by inhibiting radioadaptive signalingKazutaka Koto, Hiroaki Murata, Shinya Kimura, et al.
Cancer Letters|November 7, 2008
Clinically relevant dose of zoledronic acid inhibits spontaneous lung metastasis in a murine osteosarcoma modelKazutaka Koto, Naoyuki Horie, Shinya Kimura, et al.
Oncology Reports|December 21, 2012
Effectiveness of sulforaphane as a radiosensitizer for murine osteosarcoma cellsYasushi Sawai, Hiroaki Murata, Motoyuki Horii, et al.
Oncology Reports|June 2, 2010
Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agentsKazutaka Koto, Hiroaki Murata, Shinya Kimura, et al.
Anticancer Research|August 5, 2010
Combined effects of bisphosphonate and radiation on osteosarcoma cellsKazuteru Ryu, Hiroaki Murata, Kazutaka Koto, et al.
Pageof 2